Liver graft allocation for hepatocellular carcinoma patients: is a forced ablate-and-wait protocol nationally applicable?

Affiliations

Free article

Comment

Fateh Bazerbachi et al. Liver Transpl. 2014 May.

Free article

. 2014 May;20(5):629-30.

doi: 10.1002/lt.23849.

¹ Multiorgan Transplant, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada.

No abstract available

Comment on

Selecting patients with hepatocellular carcinoma for liver transplantation: who should receive priority?
Bazerbachi F, Aby E, Lake JR. Bazerbachi F, et al. Liver Transpl. 2013 Dec;19(12):1289-91. doi: 10.1002/lt.23791. Liver Transpl. 2013. PMID: 24214873 No abstract available.
Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.
Mehta N, Dodge JL, Goel A, Roberts JP, Hirose R, Yao FY. Mehta N, et al. Liver Transpl. 2013 Dec;19(12):1343-53. doi: 10.1002/lt.23753. Liver Transpl. 2013. PMID: 24285611 Free PMC article.
Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list.
Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Mehta N, et al. Liver Transpl. 2014 May;20(5):627-8. doi: 10.1002/lt.23847. Epub 2014 Mar 26. Liver Transpl. 2014. PMID: 24493311 Free PMC article. No abstract available.